Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Chinese Patent Office
US Department of Justice
Johnson and Johnson
Citi
Cantor Fitzgerald
Deloitte
Federal Trade Commission
Teva

Generated: February 24, 2018

DrugPatentWatch Database Preview

PROCAINAMIDE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Procainamide Hydrochloride, and when can generic versions of Procainamide Hydrochloride launch?

Procainamide Hydrochloride is a drug marketed by Ascot, Idt Australia Ltd, Ivax Sub Teva Pharms, Lannett, Lederle, Roxane, Vangard, Watson Labs, Abraxis Pharm, Hospira, Intl Medication, Nexus Pharms, Pharmafair, Smith And Nephew, Solopak, Warner Chilcott, West-ward Pharms Int, Ani Pharms Inc, Inwood Labs, and Sandoz. and is included in fifty-eight NDAs.

The generic ingredient in PROCAINAMIDE HYDROCHLORIDE is procainamide hydrochloride. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
Drug patent expirations by year for PROCAINAMIDE HYDROCHLORIDE
Pharmacology for PROCAINAMIDE HYDROCHLORIDE
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for PROCAINAMIDE HYDROCHLORIDE

US Patents and Regulatory Information for PROCAINAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 089528-001 May 3, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Intl Medication PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 088636-001 Jul 31, 1984 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 088959-001 Dec 2, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 088534-001 Dec 3, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 089029-001 Apr 17, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 088974-001 Jul 22, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Inwood Labs PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 089840-001 Mar 6, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 089027-001 Oct 22, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 089416-001 Nov 17, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Intl Medication PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 088637-001 Jul 31, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Dow
US Army
Baxter
Merck
Mallinckrodt
UBS
Medtronic
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot